1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends

Cancer/Tumor Profiling Market: Forecast until 2021

  • December 2016
  • 159 pages
  • ID: 4450353
In this report:
THE GENOMICS SEGMENT IS EXPECTED TO HOLD THE LARGEST SHARE OF ##.##% OF THE MARKET IN 2016 WHILE THE EPIGENETICS SEGMENT IS ESTIMATED TO GROW AT THE HIGHEST CAGR OF ##.##% DURING THE FORECAST PERIOD.
INDIA AND CHINA COLLECTIVELY CONTRIBUTED ~##% OF THE GLOBAL LUNG CANCER CASES IN 2012; THIS IS EXPECTED TO RISE TO ##% IN 2020.

Summary

Table of Contents

Search Inside

The overall Cancer/Tumor Profiling market is poised to reach ~$61.9B by 2021 from ~$25.8B in 2016, at a compound annual growth rate (CAGR) of 19.10 percent from 2016 to 2021. Growing number of cancer cases across the world, the rising utility of biomarkers, and availability of funding for cancer research are the main factors driving the increase of the overall Cancer/Tumor Profiling market.

In recent years, the APAC market for cancer/tumor profiling has witnessed significant increase due to the growing incidence of cancer, growing demand for better healthcare services in developing economies including India and China (CN), increasing number of contract research organizations, and rising focus of international actors on emerging industries.

In this business report, the overall Cancer/Tumor Profiling market is divided on the basis of technology, technique, application, and area. On the basis of technology, the overall cancer/tumor profiling market is mostly divided into next-generation sequencing, quantitative PCR, in situ hybridization, immunohistochemistry, and microarray. The next-generation sequencing segment is planned to account for the most important share of the cancer/tumor profiling technology market in 2016. Factors contributing to its biggest share contain advantages including reduction in sequencing costs, technology advancements in sequencing platforms, research laboratories and academicians promoting the use of NGS.

Moreover, established on technique, the cancer/tumor profiling market is broken down into genomics, proteomics, epigenetics, and metabolomics. The genomics segment is intended to account for the most important share of the cancer/tumor profiling technique market in 2016. Elements such as growing investments, grants, and funds by governments; increasing research in the field of genomics; and growing application of genomic sequencing in diagnostics are contributing to the rise of this segment.

Established on technology, the overall cancer/tumor profiling market is mostly divided into next-generation sequencing, quantitative PCR, in situ hybridization, immunohistochemistry, and microarray. The next-generation sequencing segment is forecasted to account for the biggest share of the cancer/tumor profiling technology market in 2016. Elements such as reduction in sequencing costs, technology advancements in sequencing platforms, research laboratories and academicians promoting the use of NGS, and rising awareness on NGS products and services are contributing to the increase of this segment.

New and innovative product launches was the dominant strategy approved by main industry participants to rise their share of market and cater to unmet needs.

Segment Research

From a comprehensive perspective, this market report deals with qualitative data, market value, and rise of different segments and subsegments, opposing landscape, and company analysis. The qualitative data contains several levels of industry analysis including market dynamics (drivers, industry restraints, possibilities, and segment risks), winning imperatives, and burning issues. The analysis also provides market values and info on the increase of different segments in the sector. It focuses on emerging and the high-development segments, high-growth territories, and initiatives of governments. The competitive landscape includes increase strategies approved by sector actors in the last three years. The corporation reviews include basic views on key competitors in the cancer/tumor profiling market and the product types, advancements, and strategies approved by market actors to maintain and rise their market shares in the upcoming future. The above-mentioned segment research data, current market size, and projection of future trends will facilitate top players and new sector entrants to make the essential decisions regarding product offerings, spatial focus, change in approach, Research and development investments for modernizations in products and technologies, and levels of output in order to remain profitable.

Why acquiring this study can help you:

From an insight prospect, this market research highlights on several levels of analysis - industry and company descriptions, which together comprise and examine the basic overviews on the competitive landscape; coming out and high-growth segments of the single-use bioprocessing market; high-growth areas; and sector drivers, market restraints, and alternatives.

This study furnishes highlights on the following points:

- Business entry: Exhaustive information on products provided by the top actors in the cancer/tumor profiling market

- Product improvement/Innovative products: In-depth understanding on the next technologies, analysis & growth activities, and recent product launches in the cancer/tumor profiling market

- Industry development: Highlighted information about lucrative emerging markets-the report examines the industries for cancer/tumor profiling products across several areas

- Industry diversification: Complete information about recent products, untapped areas, and recent evolutions in the cancer/tumor profiling market

- Opposing assessment: In-depth assessment of market ranking, strategies, products, and manufacturing competences of the key players in the cancer/tumor profiling market

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Amrita helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Patient Derived Xenograft/PDX Models Market: Global Forecast until 2022

  • $ 5650
  • Industry report
  • September 2017
  • by MarketsandMarkets

“PDX models market is projected to grow at a CAGR of 16.7%”The global PDX models market is estimated to grow at a CAGR of 16.7% from 2017 to 2022, to reach USD 167.6 million. The key factors driving ...

Cancer Supportive Care Sector: Worldwide Forecast until 2021

  • $ 3500
  • Industry report
  • September 2017
  • by Infiniti Research Limited

About Cancer Supportive CareCancer supportive care drugs are used for the treatment of adverse effects caused due to the cancer treatment such as chemotherapy-induced anemia, CINV, bone metastasis, cance ...

Clinical Research in Endometrial Cancer in H2, 2017

  • $ 2500
  • Industry report
  • August 2017
  • by GlobalData

Endometrial Cancer Global Clinical Trials Review, H2, 2017SummaryGlobalData’s clinical trial report, “Endometrial Cancer Global Clinical Trials Review, H2, 2017" provides an overview of Endometrial ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.